In a more recent focal segmental glomerulosclerosis clinical trial, Kopp et al. [33] studied the APOL1-asosociated nephropathy and APOL1 renal risk allele frequency in 94 cases of children and young adults. Here, APOL1 is linked to kidney disorder.